Scientific publications for BioPredictive non-invasive diagnostics

Peer-reviewed studies validating BioPredictive blood-test diagnostics for liver disease — from first-in-class development cohorts to long-term meta-analyses.

4/433 Matches for
“Glycan”

“Glycan” Clear all

  1. Altered serum N-glycomics in chronic hepatitis B patients.

    Gui HL et al. · Liver Int · 2010 Match 100

    …Our present study aimed to evaluate the use of serum glycan markers…

    FibroTest HBV

  2. Input of serum haptoglobin fucosylation profile in the diagnosis of hepatocellular carcinoma in patients with non-cirrhotic liver disease.

    Peta V et al. · Clin Res Hepatol Gastroenterol · 2020 Match 88

    ### Background Haptoglobin bifucosylated tetra-antennary glycan have been identified in patients with…

  3. Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics.

    Callewaert N et al. · Nat Med · 2004 Match 75

    We applied our 'clinical glycomics' technology, based on DNA sequencer/fragment analyzers…

    FibroTest Alcohol Other

  4. Discovery of novel biomarker candidates for liver fibrosis in hepatitis C patients: a preliminary study.

    Gangadharan B et al. · PLoS One · 2012 Match 63

    ### Background Liver biopsy is the reference standard for assessing liver fibrosis and…

    FibroTest HCV

Showing the full result list. The page is server-rendered and not paginated.